Susquehanna International Group
ELDN icon

Susquehanna International Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Susquehanna International Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
109,949
+83,152
+310% +$196K ﹤0.01% 10611
2025
Q4 		$40.5K Sell
26,797
-1,903
-7% -$4.52K ﹤0.01% 11821
2025
Q3 		$74.3K Sell
28,700
-990,219
-97% -$2.89M ﹤0.01% 11716
2025
Q2 		$2.76M Sell
1,018,919
-566,729
-36% -$1.7M ﹤0.01% 5125
2025
Q1 		$5.38M Buy
1,585,648
+1,316,623
+489% +$5.42M ﹤0.01% 3527
2024
Q4 		$1.11M Buy
269,025
+249,155
+1,254% +$982K ﹤0.01% 6695
2024
Q3 		$49.5K Sell
19,870
-1,918
-9% -$5.14K ﹤0.01% 11380
2024
Q2 		$57.5K Sell
21,788
-77,990
-78% -$186K ﹤0.01% 11349
2024
Q1 		$206K Buy
99,778
+13,455
+16% +$24K ﹤0.01% 10544
2023
Q4 		$155K Buy
86,323
+29,747
+53% +$41.3K ﹤0.01% 10945
2023
Q3 		$77.5K Buy
56,576
+6,074
+12% +$8.11K ﹤0.01% 11083
2023
Q2 		$69.2K Buy
+50,502
New +$105K ﹤0.01% 11190
2021
Q2 		– Sell
-22,247
Closed -$238K – 12704
2021
Q1 		$238K Buy
+22,247
New +$336K ﹤0.01% 11083
2020
Q4 		– Sell
-953
Closed -$16K – 11154
2020
Q3 		$16K Sell
953
-68
-7% -$670 ﹤0.01% 10391
2020
Q2 		$8K Buy
+1,021
New +$11.5K ﹤0.01% 9989
2017
Q1 		– Sell
-124
Closed -$20K – 9144
2016
Q4 		$20K Sell
124
-322
-72% -$61.7K ﹤0.01% 9426
2016
Q3 		$111K Buy
+446
New +$163K ﹤0.01% 7896
2015
Q1 		– Sell
-147
Closed -$351K – 9515
2014
Q4 		$351K Buy
+147
New +$349K ﹤0.01% 7863

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Susquehanna International Group's ELDN Position: Q1 2026 in Review

Susquehanna International Group increased its Eledon Pharmaceuticals (ELDN) stake by 310% in Q1 2026, buying an estimated $196K and bringing the position to 109,949 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #10611.

Susquehanna International Group first reported a position in ELDN in Q4 2014 and has held it in 18 quarters since. The position peaked at $5.38M in Q1 2025. 121 funds tracked by Wall St. Rank hold ELDN as of Q1 2026.

  • Susquehanna International Group held 109,949 shares of Eledon Pharmaceuticals worth $339K as of Q1 2026.
  • Susquehanna International Group bought 83,152 Eledon Pharmaceuticals shares in Q1 2026, an estimated $196K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10611 holding.
  • Susquehanna International Group first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 18 quarters since.
  • Susquehanna International Group's Eledon Pharmaceuticals position peaked at $5.38M in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.